Drug Approval | July 24, 2024
Zydus receives USFDA’s final approval for Valsartan Tablets
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, India
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, India
The inspections concluded with no Form 483 observations or significant critical findings
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
KIMS already have a multi-specialty hospital and gastro unit at Vizag
Subscribe To Our Newsletter & Stay Updated
